SCHEMBL29990795

SCHEMBL29990795

NC(=O)c1cc2ccc(F)c(F)c2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4A3 P38919 1/20 0.48
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
KMT2A Q03164 1/20 0.39
MAP2K1 Q02750 2/20 0.38
HRH4 Q9H3N8 8/20 0.38
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
MAP2K2 P36507 1/20 0.35
MPL P40238 1/20 0.35
MAP2 P11137 1/20 0.35
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22395050 0.84 EIF4A3 (0.65) EIF4A3ALDH1A1HPGDHSD17B10MEN1
SCHEMBL29425105 0.84 EIF4A3 (0.65) EIF4A3ALDH1A1HPGDHSD17B10MEN1
SCHEMBL29062816 0.83 MAP2K1 (0.43) EIF4A3ALDH1A1HPGDHSD17B10MEN1
SCHEMBL29063065 0.83 TNF (0.42) EIF4A3ALDH1A1HPGDHSD17B10MEN1
SCHEMBL28064616 0.81 HRH4 (0.40) EIF4A3ALDH1A1HPGDHSD17B10MEN1
SCHEMBL7942068 0.79 HRH4 (0.57) ALDH1A1HPGDHSD17B10MEN1USP2
SCHEMBL30544758 0.77 IDO1 (0.41) EIF4A3MAP2K1HRH4IDO1TDO2
SCHEMBL29063177 0.77 IDO1 (0.54) EIF4A3MAP2K1HRH4IDO1TDO2
SCHEMBL5359001 0.75 ALOX15 (0.57) EIF4A3ALDH1A1HPGDHSD17B10MEN1
SCHEMBL25758822 0.75 ALOX15 (0.57) EIF4A3ALDH1A1TP53POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453676-B2 Inhibitors of protein arginine deiminases FORWARD THERAPEUTICS, INC. (US) 2022-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453676-B2 Inhibitors of protein arginine deiminases PADI2, PADI1, PADI4 EIF4A3 3899/4885ALDH1A1 1830/4885HPGD 266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.